التفاصيل البيبلوغرافية
| العنوان: |
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial |
| المؤلفون: |
Zhong, Wen-Zhao, Yan, Hong-Hong, Chen, Ke-Neng, Chen, Chun, Gu, Chun-Dong, Wang, Jun, Yang, Xue-Ning, Mao, Wei-Min, Wang, Qun, Qiao, Gui-BinAff1, Aff8, Cheng, Ying, Xu, Lin, Wang, Chang-Li, Chen, Ming-Wei, Kang, Xiao-Zheng, Yan, Wan-Pu, Liao, Ri-Qiang, Yang, Jin-Ji, Zhang, Xu-Chao, Liu, Si-Yang, Zhou, Qing, Wu, Yi-LongAff1, IDs41392022012863_cor22 |
| المصدر: |
Signal Transduction and Targeted Therapy. 8(1) |
| قاعدة البيانات: |
Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder